Clinical Characteristics, Respiratory Mechanics, and Outcomes in Critically Ill Individuals With COVID-19 Infection in an Underserved Urban Population

References

1. 1.↵
   World Health Organization. Novel coronavirus - China. Available at: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en. Accessed February 3, 2021.
2. 2.↵
   1. Huang C,
   2. Wang Y,
   3. Li X,
   4. Ren L,
   5. Zhao J,
   6. Hu Y,
   7. et al

   . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.

   OpenUrlCrossRefPubMed
3. 3.↵
   Centers for Disease Control and Prevention. COVID view summary ending on Feb 26, 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html. Accessed February 3, 2021.
4. 4.↵
   APM Research Labs. The color of coronavirus: COVID-19 deaths by race and ethnicity in the U.S. Available at: https://www.apmresearchlab.org/covid/deaths-by-race. Accessed February 3, 2021.
5. 5.↵
   1. Richardson S,
   2. Hirsch JS,
   3. Narasimhan M,
   4. Crawford JM,
   5. McGinn T,
   6. Davidson KW,
   7. et al

   . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323(20):2052-2059.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Zhou F,
   2. Yu T,
   3. Du R,
   4. Fan G,
   5. Liu Y,
   6. Liu Z,
   7. et al

   . Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Matsumoto K,
   2. Saito H

   . Does asthma affect morbidity or severity of COVID-19? J Allergy Clin Immunol 2020;146(1):55-57.

   OpenUrlCrossRef
8. 8.↵
   1. Patel AB,
   2. Verma A

   . COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA 2020;323(18):1769-1770.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Lippi G,
   2. Plebani M

   . Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta 2020;505:190-191.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Cheng Y,
    2. Luo R,
    3. Wang K,
    4. Zhang M,
    5. Wang Z,
    6. Dong L,
    7. et al

    . Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829-838.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Siddiqi HK,
    2. Mehra MR

    . COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020;39(5):405-407.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Yang X,
    2. Yu Y,
    3. Xu J,
    4. Shu H,
    5. Xia J,
    6. Liu H,
    7. et al

    . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481.

    OpenUrlPubMed
13. 13.↵
    1. Gattinoni L,
    2. Coppola S,
    3. Cressoni M,
    4. Busana M,
    5. Rossi S,
    6. Chiumello D

    . COVID-19 does not lead to a "typical" acute respiratory distress syndrome. Am J Respir Crit Care Med 2020;201(10):1299-1300.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Ziehr DR,
    2. Alladina J,
    3. Petri CR,
    4. Maley JH,
    5. Moskowitz A,
    6. Medoff BD,
    7. et al

    . Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med 2020;201(12):1560-1564.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Brower RG,
    2. Matthay MA,
    3. Morris A,
    4. Schoenfeld D,
    5. Thompson BT,
    6. Wheeler A

    Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. NEJM 2000;342(18):1301-1308.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Bellani G,
    2. Laffey JG,
    3. Pham T,
    4. Fan E,
    5. Brochard L,
    6. Esteban A,
    7. et al

    . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788-800.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Guérin C,
    2. Reignier J,
    3. Richard J-C,
    4. Beuret P,
    5. Gacouin A,
    6. Boulain T,
    7. et al

    . Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159-2168.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Alhazzani W,
    2. Møller MH,
    3. Arabi YM,
    4. Loeb M,
    5. Gong MN,
    6. Fan E,
    7. et al

    . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020;46(5):854-887.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Wu C,
    2. Chen X,
    3. Cai Y,
    4. Xia J,
    5. Zhou X,
    6. Xu S,
    7. et al

    . Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180(7):934-943.

    OpenUrl
20. 20.↵
    1. Paranjpe I,
    2. Fuster V,
    3. Lala A,
    4. Russak AJ,
    5. Glicksberg BS,
    6. Levin MA,
    7. et al

    . Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol 2020;76(1):122-124.

    OpenUrlFREE Full Text